Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Dulaglutide

GLP-1 Therapy: The Role of IL-6 Signaling and Adipose Tissue Remodeling in Metabolic Response

Company n/r · Phase 4 · Completed · Enrollment 23

NCT04387201

Participants reaching a weight loss threshold

Participants reaching threshold, %

Source: Cited trial source. The denominator is the source figure, when it states one.

No selected arm reports a responder percent.

Show as table
Arm≥5%≥10%≥15%≥20%
Cyanocobalamin, then Dulaglutiden/rn/rn/rn/r
Dulaglutide, then Cyanocobalaminn/rn/rn/rn/r

Not shown

  • Cyanocobalamin, then Dulaglutide: endpoint not reported
  • Dulaglutide, then Cyanocobalamin: endpoint not reported